Triage Survey for Psychiatry Research Eligibility
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Adams Clinical
- Study ID
- NCT05800925
- Status
- Recruiting
Conditions
- Borderline Personality Disorder
- Generalized Anxiety Disorder
- Major Depressive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Survey — OTHERParticipants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.
Study Details
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Key Dates
- Start date
- Dec 21, 2021
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 20,000 participants (estimated)
Primary Outcome Measure
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study [ Time Frame: Up to 52 weeks ]
Central Contacts
- Miriam Evans, PhD617-744-8542
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Adams Clinical, Boston | Boston | Massachusetts | 02116 | Dyanna Domilici, MD (PRINCIPAL_INVESTIGATOR) |
| Adams Clinical, Watertown | Watertown | Massachusetts | 02472 | Miriam Evans, PhD (PRINCIPAL_INVESTIGATOR) |
| Adams Clinical, Harlem | New York | New York | 10029 | Wesley Gregory, PHD (PRINCIPAL_INVESTIGATOR) |
| Adams Clinical, Bronx | The Bronx | New York | 10461 | Shama Farooq, MD (PRINCIPAL_INVESTIGATOR) |
| Adams Clinical, Philadelphia | Philadelphia | Pennsylvania | 19104 | Cassie Blanchard, PHD (PRINCIPAL_INVESTIGATOR) |
| Adams Clinical, Dallas | DeSoto | Texas | 75115 | Rajinder Shiwach, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
Related Studies
- DBS for DepressionRecruiting · Baylor College of Medicine · Dallas, Texas
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar DisorderEARLY_PHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Biomarker-guided rTMS for Treatment Resistant DepressionPHASE3 · Recruiting · Weill Medical College of Cornell University · Stanford, California
- Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel TherapeuticsRecruiting · Massachusetts General Hospital · Boston, Massachusetts